搜索
 > 【ADAM17】重组蛋白信息

ADAM17信息

英文名称:Disintegrin and metalloproteinase domain-containing protein 17
中文名称:去整合素和金属蛋白酶-17
靶点别称:CD_antigen=CD156b,TACE,TNF-alpha-converting enzyme,CSVP ,ADAM 17,ADAM17,Snake venom-like protease,Disintegrin and metalloproteinase domain-containing protein 17,TNF-alpha convertase
上市药物数量:0
临床药物数量:3
最高研发阶段:临床二期

ADAM17产品列表

产品库
物种
标签
属性
货号 物种 产品描述 蛋白结构 纯度 活性
AD7-M52H1
Mouse
Mouse ADAM17 / TACE / CD156b Protein, His Tag
 
评论(0)
 

ADAM17 分子别名

ADAM17,TACE,CD156b

ADAM17 分子背景

Disintegrin and metalloproteinase domain-containing protein 17 (ADAM17), a member of the ADAM protein family of disintegrins and metalloproteases, is also known as TNF-alpha convertase, TNF-alpha-converting enzyme and CD156b, which contains one disintegrin domain and one peptidase M12B domain. ADAM17 can cleave the membrane-bound precursor of TNF-alpha to its mature soluble form. ADAM17 is also responsible for the proteolytical release of soluble JAM3 from endothelial cells surface (By similarity) and proteolytic release of several other cell-surface proteins, including p75 TNF-receptor, interleukin 1 receptor type II, p55 TNF-receptor, transforming growth factor-alpha, L-selectin, growth hormone receptor, MUC1 and the amyloid precursor protein. Furthermore, ADAM17 acts as an activator of Notch pathway by mediating cleavage of Notch, generating the membrane-associated intermediate fragment called Notch extracellular truncation.

ADAM17 参考文献

ADAM17临床药物信息

英文名称 研发代码 研发阶段 公司 适应症 临床试验
Aderbasib INCB-7839; INCB-007839; INC-B007839,INCB007839,INCB7839 临床二期 Incyte 乳腺癌, 实体瘤, 非霍奇金淋巴瘤 详情
BMS-561392 BMS-561392; DPC-333,BMS561392,DPC333 临床二期 百时美施贵宝 类风湿性关节炎, 炎症性肠病
Apratastat TMI-005,TMI005 临床二期 辉瑞 类风湿性关节炎 详情

消息提示

请输入您的联系方式,再点击提交!

确定